Patent · US Active

Use of gp130 activators in diabetic neuropathy

US8278286B2 · kind B2 · utility

0Cited by

3References

15Claims

0Family size

Assignee

MERCK SERONO SA · CH

Inventors

Michel Dreano · Brive-la-Gaillarde, FR
Pierre-Alain Vitte · Annemasse, FR

Key dates

Filing date	Apr 5, 2010
Grant date	Oct 2, 2012
Priority date	—
Expiry date	Apr 5, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/10011
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use a substance signaling through gp130 for the manufacture of a medicament for the treatment and/or prevention of diabetic neuropathy. The use of IL-6 is preferred.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.